FFRct vs SignalHF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
FFRct is designed for the non-invasive diagnosis and assessment of coronary artery disease using CCTA scans to create 3D models and analyze blood flow. In contrast, SignalHF focuses on predicting heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices. Therefore, FFRct is suited for guiding CAD treatment decisions, while SignalHF is for proactive management and early intervention in heart failure patients.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool designed to assess blood flow in coronary arteries from CCTA scans, aiding in the diagnosis of coronary artery disease and guiding treatment strategies. SignalHF by Implicity is an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices, enabling early intervention and personalized care.
FFRct requires data from coronary computed tomography angiography (CCTA) scans to create personalized 3D models and analyze blood flow. SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies from various cardiac implantable electronic devices (CIEDs) such as pacemakers, ICDs, and CRTs.
FFRct utilizes AI and computational fluid dynamics (CFD) to generate personalized 3D digital models of coronary arteries and calculate FFRct values. SignalHF employs an FDA-cleared AI algorithm to analyze data from CIEDs and generate risk scores for predicting heart failure hospitalizations.
For FFRct Analysis, there is a specified CMS payment rate of $1,017 for 2025, with commercial payer rates varying. Reimbursement details for SignalHF are not specified, and physicians would need to contact the company for pricing information.